Crossmark

Gametocyte carriage of Plasmodium falciparum (pfs25) and Plasmodium vivax (pvs25) during mass screening and treatment in West Timor, Indonesia: a longitudinal prospective study

Crossref DOI link: https://doi.org/10.1186/s12936-021-03709-y

Published Online: 2021-04-09

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kosasih, Ayleen

Koepfli, Cristian

Dahlan, M. Sopiyudin

Hawley, William A.

Baird, J. Kevin

Mueller, Ivo

Lobo, Neil F.

Sutanto, Inge https://orcid.org/0000-0003-2488-5133
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct01878357 at ClinicalTrials.gov

Documents that mention this clinical trial

Gametocyte carriage of Plasmodium falciparum (pfs25) and Plasmodium vivax (pvs25) during mass screening and treatment in West Timor, Indonesia: a longitudinal prospective study
https://doi.org/10.1186/s12936-021-03709-y
Funding

Funding for this research was provided by:

Bill and Melinda Gates Foundation (45114)

Kementerian Riset Teknologi Dan Pendidikan Tinggi Republik Indonesia (120/SP2H/PTNBH/DRPM/2018)
License Information

Text and Data Mining valid from 2021-04-09

Version of Record valid from 2021-04-09
More Information

Article History

Received: 18 November 2020

Accepted: 23 March 2021

First Online: 9 April 2021

Declarations

:

: This study has been approved by Ethical committee of Medical Faculty, University of Indonesia no. 37/H2.F1/ETIK/2013. Informed consent was obtained from all study subjects prior to samples taking.

: Not applicable.

: The author(s) declare(s) that they have no competing interests.

Document is current

Any future updates will be listed below